Gendius is crowdfunding soon!
Gendius is an innovative, exciting company that is changing the way that people with diabetes live with their condition. We have developed an app platform- intellin® -that helps people to understand where complications might arise, and how best to reduce them.

We will soon be launching a crowdfunding campaign to give you the unique opportunity to contribute to the future of our company. When the campaign opens, you will be able to help us raise capital in exchange for shares in our company.

Your email will be collected and stored by us purely for periodic updates about our crowdfunding campaign. You may unsubscribe at any time. Your email will not be shared with any third parties.

What is Crowdfunding?
Crowdfunding is where a large number of people pool their money together to back an idea or business, typically via an online platform. This enables you to invest alongside a group of people (the “crowd”) in a company that isn’t listed on the stock market, in return for shares in that company.

Find out more at:
https://www.crowdcube.com/explore/entrepreneur-articles/introduction-to-crowdfunding

Why are we crowdfunding?
Gendius is rapidly growing. In the past year we have released intellin® into both the UK and EU and thousands have already downloaded the platform. The platform is also attracting interesting from insurance companies and big pharma, as well as the NHS. We have ambitious plans to connect intellin® to dozens- if not hundreds- of other apps and medical devices as well as continue to develop the Artificial Intelligence that is at the heart of the app.
Join our crowd today
If you are interested in joining us on this exciting journey, please enter your email address along with a non-committal indication of the level of support you are considering giving us, and we will keep you updated on the progress of our campaign. By pre-registering, you will also be given priority access when the campaign goes live.
Growing our team

We need to grow our brilliant in-house team to help us achieve our ambition. As well as the AI and connectivity, we need to continue to get accreditations at the highest level to reassure users that intellin® is as good as we say it is! This means we need to reinforce our development team, as well as bring in regulatory and clinical support.
Find out more
Find out more about us and what we do
www.gendius.co.uk
Next
Never submit passwords through Google Forms.
This content is neither created nor endorsed by Google. Report Abuse - Terms of Service